Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan’s MHLW Approves Optical Topography Imaging As Advanced Medical Technology

This article was originally published in PharmAsia News

Executive Summary

Japan's Ministry of Health, Labor and Welfare approved March 10 optical topography imaging as a class two advanced medical technology. The testing is indicated to diagnose patients showing symptoms of depression, bipolar disorder and schizophrenia. Depression caused by organic disease is excluded. The expert council at the MHLW considers the imaging technology relatively effective compared to current technology. The Ministry plans to apply medical insurance for the diagnostic beginning April 1. After insurance coverage, patients will pay ¥13,000 for a regular testing. The approval condition for medical facilities is to establish at least one neurological physician and one clinical technologist. (Click here for more - Japanese language



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts